Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
EBITDA
$514.70M
TTM · Period ending: · USD
BIO EBITDA
Latest reported$514.70Mperiod ending
Latest reported$514.70Mperiod ending
BIO EBITDA ($10.70M → $514.70M)
Annual EBITDA
High-resolution chart · PNG
BIO ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 1,209,900,000 | |
| -2,142,000,000 | |
| -654,800,000 | |
| -4,528,859,000 | |
| 5,588,206,000 | |
| 5,078,468,000 | |
| 2,418,697,000 | |
| 674,721,000 | |
| 269,519,000 | |
| 206,402,000 | |
| 299,339,000 | |
| 303,588,000 | |
| 320,856,000 | |
| 411,419,000 | |
| 419,982,000 | |
| 392,900,000 | |
| 334,556,000 | |
| 272,056,000 | |
| 219,749,000 | |
| 229,400,000 | |
| 176,298,000 | |
| 173,046,000 | |
| 189,433,000 | |
| 180,138,000 | |
| 153,326,000 | |
| 110,076,000 | |
| 76,094,000 | |
| 52,120,000 | |
| 46,100,000 | |
| 56,900,000 | |
| 56,400,000 | |
| 53,500,000 | |
| 27,000,000 | |
| 28,400,000 | |
| 34,200,000 | |
| 34,700,000 | |
| 29,000,000 | |
| 26,200,000 | |
| 21,500,000 | |
| 15,200,000 | |
| 10,700,000 |